ARTBIO Launches to Develop New Class of Alpha Radioligand Therapies Designed to Maximize Therapeutic Potential June 21, 2023
ARTBIO emerges with $23M to make radioligand therapies for prostate cancer, with field still in ‘early days’ June 21, 2023
Silver Cross Hospital Expands Use of Kyruus’ Award-Winning Online Scheduling Solution Across Specialties and Services June 20, 2023
Equip taps healthcare exec Nikia Bergan as new president to scale up virtual eating disorder treatment services June 20, 2023
Denali Therapeutics Announces Robust Reduction in Neurofilament Light (NfL) with DNL310 (ETV:IDS) Treatment in MPS II (Hunter Syndrome) June 20, 2023